(Q51350319)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

A Campanati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

G Ganzetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Damiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Sandroni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

L Rosa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Benedetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

A Offidani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

13 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

10 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

839-846

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23065020%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis and clinical features of psoriasis

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

From the metabolic syndrome to NAFLD or vice versa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Effect of etanercept on insulin sensitivity in nine patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Pathogenesis of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0678-9

Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

21 January 2018

1 reference

12 December 2020

Validation of a screening questionnaire for alcoholism (MAST) in an Italian sample

1 reference

12 December 2020

New clinical score to diagnose nonalcoholic steatohepatitis in obese patients

1 reference

12 December 2020

Association between obesity measured by different parameters and severity of psoriasis

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study

1 reference

12 December 2020

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

12 December 2020

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation

1 reference

12 December 2020

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

12 December 2020

Body mass index, waist hip ratio, and waist circumference: which measure to classify obesity?

1 reference

12 December 2020

Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD)

1 reference

12 December 2020